Lambert C, Rouleau J L
Research Center, Hôpital du Sacré-Coeur de Montréal, Quebec, Canada.
Cardiovasc Drugs Ther. 1989 Jan;2(6):717-26. doi: 10.1007/BF00133199.
Due to the narrow therapeutic-to-toxic ratio of digoxin, numerous studies have been done to assess the optimal digoxin level in patients with congestive heart failure. A digoxin level of 0.7-1.5 ng/mL (or 0.9-2.0 nMol/L) is generally considered optimal, but even at these levels toxicity may occur in certain clinical situations such as severe pulmonary disease or when electrolyte or metabolic disturbances are present. The optimal daily maintenance dose of digoxin depends on the preparation given and can be calculated by the equation of Jelliffe, which is largely based on the creatinine clearance of the patient. The daily digoxin dose must also be adjusted to take into consideration disease processes or concomitant drug therapy that can alter the volume of distribution, the biotransformation, or the excretion of the drug.
由于地高辛的治疗窗较窄,已经开展了大量研究来评估充血性心力衰竭患者的最佳地高辛水平。地高辛水平在0.7 - 1.5 ng/mL(或0.9 - 2.0 nMol/L)通常被认为是最佳的,但即使在这些水平,在某些临床情况下,如严重肺部疾病或存在电解质或代谢紊乱时,仍可能发生毒性反应。地高辛的最佳每日维持剂量取决于所使用的制剂,可通过杰利夫公式计算,该公式主要基于患者的肌酐清除率。每日地高辛剂量还必须进行调整,以考虑可能改变药物分布容积、生物转化或排泄的疾病过程或合并药物治疗。